CREON(R) (pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption In Children With Cystic Fibrosis
Solvay Pharmaceuticals, Inc... (Source: Endocrinology News From Medical News Today)
Results Published In Journal of Cystic Fibrosis Confirm Creon (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis
- Data Support Safe and Effective Use of CREON(R) to Meet
Critical Medical Need for CF Patients -
MARIETTA, Ga., Oct. 9 /PRNewswire/ -- Solvay Pharmaceuticals,
Inc. announced today that Phase III data published in the Journal
of Cystic Fibrosis... (Source: Drugs.com - Clinical Trials)
